In trading on Wednesday, shares of Integer Holdings Corp (Symbol: ITGR) crossed above their 200 day moving average of $88.31, changing hands as high as $91.31 per share. Integer Holdings Corp shares are currently trading up about 4.9% on the day. The chart below shows the one
In trading on Wednesday, shares of Integer Holdings Corp (Symbol: ITGR) crossed above their 200 day moving average of $88.31, changing hands as high as $91.31 per share. Integer Holdings Corp shares are currently trading up about 4.9% on the day. The chart below shows the one
In trading on Wednesday, shares of Avient Corp (Symbol: AVNT) crossed below their 200 day moving average of $34.66, changing hands as low as $34.39 per share. Avient Corp shares are currently trading off about 2.4% on the day. The chart below shows the one year performance of
In trading on Wednesday, shares of Avient Corp (Symbol: AVNT) crossed below their 200 day moving average of $34.66, changing hands as low as $34.39 per share. Avient Corp shares are currently trading off about 2.4% on the day. The chart below shows the one year performance of
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on April 2, Shoe Carnival, Inc.'s EVP - CFO, W. Kerry Jackson, invested $500,030.00 into 31,000 shares of SCVL, for a cost per share of $1
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on April 2, Shoe Carnival, Inc.'s EVP - CFO, W. Kerry Jackson, invested $500,030.00 into 31,000 shares of SCVL, for a cost per share of $1
In trading on Wednesday, shares of the ProShares UltraShort MSCI Japan ETF (Symbol: EWV) entered into oversold territory, changing hands as low as $18.18 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator u
In trading on Wednesday, shares of the ProShares UltraShort MSCI Japan ETF (Symbol: EWV) entered into oversold territory, changing hands as low as $18.18 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator u
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 7, Automatic Data Processing Inc.'s Director, Robert Holmes Swan, invested $745,694.95 into 3,619 shares of ADP, for a cost per sha
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 7, Automatic Data Processing Inc.'s Director, Robert Holmes Swan, invested $745,694.95 into 3,619 shares of ADP, for a cost per sha
Martin Barraud/iStock via Getty Images Nouveau Monde Graphite ( NMG ) said Wednesday it has secured the financing structure for its planned Phase 2 Matawinie graphite mine in Quebec, expecting to formally green-light plans this week to build one of North America's few graphite projects. A previously announced ~US$645M financing package was backed by shareholders, Bloomberg reported, adding that a ...
Martin Barraud/iStock via Getty Images Nouveau Monde Graphite ( NMG ) said Wednesday it has secured the financing structure for its planned Phase 2 Matawinie graphite mine in Quebec, expecting to formally green-light plans this week to build one of North America's few graphite projects. A previously announced ~US$645M financing package was backed by shareholders, Bloomberg reported, adding that a construction team is already on site and more than 50% of the project's capital expenses are secured through contracts; costs are estimated at ~$474M, and commissioning is projected by year-end 2028. While NMG's ( NMG ) ambitions have been slowed down by automakers' pullback on electric vehicles, "I never thought the mining project wouldn't get off the ground," CEO Eric Desaulniers told Bloomberg in an interview. "It is too solid and too far along—and too necessary, too." Desaulniers said the challenges tied to slower EV adoption have pushed the company to diversify its potential customer base for graphite concentrate, including the energy storage and steelmaking industries. NMG ( NMG ) said it expects to declare a positive final investment decision for the project upon closing of the private placements and the satisfaction of conditions of the bought-deal public offering following shareholders’ approval. More on Nouveau Monde Graphite Nouveau Monde Graphite: Updated Feasibility Study Isn't Compelling Enough Financial information for Nouveau Monde Graphite
Avidity Partners Management disclosed a buy of 259,700 shares of Enliven Therapeutics (NASDAQ:ELVN) in its May 13, 2026, SEC filing, an estimated $7.19 million transaction based on quarterly average pricing. According to a SEC filing dated May 13, 2026, Avidity Partners Management bought 259,700 additional shares of Enliven Therapeutics during the first quarter of 2026. The estimated value of this...
Avidity Partners Management disclosed a buy of 259,700 shares of Enliven Therapeutics (NASDAQ:ELVN) in its May 13, 2026, SEC filing, an estimated $7.19 million transaction based on quarterly average pricing. According to a SEC filing dated May 13, 2026, Avidity Partners Management bought 259,700 additional shares of Enliven Therapeutics during the first quarter of 2026. The estimated value of this purchase was $7.19 million, calculated using the average closing price for the quarter. The quarter-end value of the position rose by $14.33 million, a figure that includes both trading activity and stock price appreciation. Enliven Therapeutics is a clinical-stage biotechnology company specializing in the discovery and development of novel small molecule inhibitors for oncology indications. The company's strategic focus on kinase inhibitors positions it to address significant unmet needs in cancer treatment, leveraging a pipeline of differentiated assets. With a lean workforce and a targeted R&D approach, Enliven aims to establish a competitive edge through innovation and clinical advancement in the biopharmaceutical sector. Continue reading
In trading on Wednesday, shares of the ProShares UltraShort MSCI Emerging Markets ETF (Symbol: EEV) entered into oversold territory, changing hands as low as $11.7816 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysi
In trading on Wednesday, shares of the ProShares UltraShort MSCI Emerging Markets ETF (Symbol: EEV) entered into oversold territory, changing hands as low as $11.7816 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysi
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on February 24, Hamilton Lane Incorporated - Class A's Director, David J. Berkman, invested $1,010,000.00 into 10,000 shares of HLNE, for
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on February 24, Hamilton Lane Incorporated - Class A's Director, David J. Berkman, invested $1,010,000.00 into 10,000 shares of HLNE, for
Cisco's fourth-quarter sales forecast topped estimates and the company announced plans to cut thousands of jobs. Lindsey Bell of 248 Ventures reacts to the report on "Bloomberg The Close." (Source: Bloomberg)
Cisco's fourth-quarter sales forecast topped estimates and the company announced plans to cut thousands of jobs. Lindsey Bell of 248 Ventures reacts to the report on "Bloomberg The Close." (Source: Bloomberg)
IceCure Medical ( Nasdaq: ICCM ) on Wednesday said it received a 180-day extension from Nasdaq to regain compliance with the exchange's minimum bid price requirement. The company now has until November 9, 2026, to meet Nasdaq's requirement that its shares trade at a minimum bid price of $1.00 for at least 10 consecutive business days. Nasdaq granted the extension after determining the company met ...
IceCure Medical ( Nasdaq: ICCM ) on Wednesday said it received a 180-day extension from Nasdaq to regain compliance with the exchange's minimum bid price requirement. The company now has until November 9, 2026, to meet Nasdaq's requirement that its shares trade at a minimum bid price of $1.00 for at least 10 consecutive business days. Nasdaq granted the extension after determining the company met all other applicable listing requirements for the Nasdaq Capital Market, except for the bid price rule, IceCure said. The company said it may consider a reverse share split if necessary to regain compliance. IceCure first received notice from Nasdaq on November 12, 2025, that its shares had failed to meet the minimum bid price requirement for 30 consecutive business days. The initial 180-day compliance period expired on May 11, 2026. The notification has no immediate effect on the listing or trading of the company's shares, which will continue trading on the Nasdaq Capital Market under the ticker "ICCM." Source: Press Release More on IceCure Medical IceCure Medical GAAP EPS of $0.06, revenue of $911M Quant snapshot: Beachbody, Deutsche Telekom among top-rated names as IceCure Medical, Fold Holdings lag Seeking Alpha’s Quant Rating on IceCure Medical
In trading on Wednesday, shares of the GraniteShares 2x Short TSLA Daily ETF (Symbol: TSDD) entered into oversold territory, changing hands as low as $6.57 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator
In trading on Wednesday, shares of the GraniteShares 2x Short TSLA Daily ETF (Symbol: TSDD) entered into oversold territory, changing hands as low as $6.57 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator
Investors following a possible Stellantis (NYSE: STLA) turnaround likely know the automaker's plate is full. It has to transition into new leadership, repair relations with its dealership network and suppliers, regain market share in Europe with intensifying Chinese competition, and digest a massive $26 billion charge to scale back electric vehicle (EV) ambitions. It's also facing a massive decisi...
Investors following a possible Stellantis (NYSE: STLA) turnaround likely know the automaker's plate is full. It has to transition into new leadership, repair relations with its dealership network and suppliers, regain market share in Europe with intensifying Chinese competition, and digest a massive $26 billion charge to scale back electric vehicle (EV) ambitions. It's also facing a massive decision about which brands to invest in to drive its global turnaround, and finally, we have a little insight into exactly how it plans to accomplish this. Stellantis, which was formed in 2021 via a merger of Fiat Chrysler and PSA Group , combined a number of brands that investors frequently complained overlapped and weren't receiving the investment they needed to thrive. While the company lacked identity and thriving brands, its global sales languished and its valuation plunged compared to Detroit rivals. Continue reading
The Federal Communications Commission yesterday approved EchoStar's sales of spectrum licenses to AT&T and Starlink operator SpaceX. The deals are worth $40 billion in total. The orders, issued by the agency's Wireless Telecommunications Bureau and Space Bureau, aren't surprising given that FCC Chairman Brendan Carr essentially forced EchoStar to sell the licenses. Last year, Carr threatened to re...
The Federal Communications Commission yesterday approved EchoStar's sales of spectrum licenses to AT&T and Starlink operator SpaceX. The deals are worth $40 billion in total. The orders, issued by the agency's Wireless Telecommunications Bureau and Space Bureau, aren't surprising given that FCC Chairman Brendan Carr essentially forced EchoStar to sell the licenses. Last year, Carr threatened to revoke the licenses after SpaceX alleged that EchoStar subsidiary Dish Network “barely uses” the spectrum to provide mobile service to US consumers. Dish had obtained a deadline extension for its network deployment obligations from the Biden-era FCC, and Carr objected to the agreement made with the previous administration. After Carr's threat, the Charlie Ergen-led EchoStar struck deals to sell spectrum licenses to SpaceX for $17 billion and to AT&T for $23 billion . Read full article Comments
Mark_KA Ford Motor Company ( F ) was the top gainer in the S&P 500 Index on Wednesday as investors seized on the potential for the Detroit automaker to benefit from its relationship with CATL by offering battery energy storage systems for utility, data center, and commercial customers in the U.S. Morgan Stanley highlighted that investors may be underestimating Ford's ( F ) foray into the energy st...
Mark_KA Ford Motor Company ( F ) was the top gainer in the S&P 500 Index on Wednesday as investors seized on the potential for the Detroit automaker to benefit from its relationship with CATL by offering battery energy storage systems for utility, data center, and commercial customers in the U.S. Morgan Stanley highlighted that investors may be underestimating Ford's ( F ) foray into the energy storage market. "We find that investors are overlooking this opportunity and its potential to drive improved profitability within Ford's Model e segment and believe that Ford's licensing agreement with CATL is a key competitive differentiator not fully understood by the market," updated analyst Daniela Haigian. "We believe that there is a fairly high likelihood that Ford signs an ESS supply agreement with large commercial customers, and potentially hyperscalers, over the next few months," she added. The firm estimates that Ford Energy could be worth $10B, assuming a 17.5X multiple on ~$588M of EBIT once it ramps up to 20 GWh of capacity. Shares of Ford ( F ) ripped a 13.2% gain on Wednesday. More on Ford Ford Motor Company (F) Q1 2026 Earnings Call Transcript Ford Motor Company 2026 Q1 - Results - Earnings Call Presentation Ford's Highly Touted BEV Czar Leaves, His Exit Won't Quickly Change Things Ford's April vehicle sales decline 14.4% Detroit automakers warn commodity spike could add $5B in costs